LOOP DIAGNOSTICS S.L.

Loop Diagnostics S.L. is a Spanish biotech company founded in 2018, primarily focused on revolutionizing the early detection and diagnosis of sepsis (a life-threatening condition caused by the body’s response to infection). The company has developed the SeptiLoop system, a pioneering in vitro cellular immunoassay that identifies sepsis after the first hour of a bloodstream infection. Unlike traditional methods, which often rely on slow pathogen identification (taking 48–72 hours) or non-specific clinical signs, Loop Diagnostics’ technology measures the patient’s immune response to bacteria. Specifically, it assesses sepsis-induced immunosuppression by identifying key immune activity biomarkers, such as the lack of TNF-a production, to predict bacteremia. This approach offers a crucial advantage: it provides a rapid diagnostic solution, delivering results in under three hours. This speed is vital, as timely treatment initiation is critical to reducing the high mortality rate associated with sepsis. The SeptiLoop system is a disposable kit and a cost-effective, easy-to-implement point-of-care (POC) solution for emergency and critical care units. Loop Diagnostics aims to significantly improve patient outcomes, combat antimicrobial resistance by enabling more targeted antibiotic use, and reduce healthcare costs linked to delayed sepsis diagnosis. Headquartered in Barcelona, Spain, the company has successfully completed clinical trials and regulatory approval in multiple international hospitals and is actively working on market entry and international expansion.